Stocks · US
DGX
XNYS
Quest Diagnostics Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E24.20x
P/B3.41x
P/S2.22x
EPS$9.59
ROE14.09%
ROA6.25%
Dividend yield1.42%
EV/EBITDA13.82x
Debt/Equity0.75
Free cash flow$1.3B
Returns and 52-week range
1W-1.54%
1M-3.69%
3M+9.69%
6M+16.05%
1Y+27.36%
YTD+31.42%
52W high$248.84
52W low$171.18
From 52W high-8.22%
Company
HeadquartersSecaucus, NJ
Employees57,000
Listed1996-12-17
Websitewww.questdiagnostics.com
SECFilings
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Roivant Sciences Ltd. Common Shares | $25.8B | — | 6.11 | +1.72% |
| Royalty Pharma plc Class A Ordinary Shares | $25.2B | 30.96 | 3.69 | -11.76% |
| West Pharmaceutical Services, Inc. | $26.5B | 46.94 | 8.87 | +9.61% |
| 가단트 헬스 | $25.1B | — | — | +5.75% |
| 앨나일램 파머슈티컬스 | $29.4B | 36.42 | 21.73 | -15.85% |
| 랩코프 | $25.0B | 24.97 | 2.91 | -4.64% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.